Cimetidine 200

The dosage of cimetidine varies significantly based on the condition being treated and the patient's overall health.

• Active Duodenal Ulcer: The standard adult dose is 800 mg taken once daily at bedtime. Alternatively, 300 mg may be taken four times daily (with meals and at bedtime) or 400 mg twice daily. Most ulcers heal within 4 to 6 weeks.
• Maintenance of Duodenal Ulcer: To prevent recurrence, a lower dose of 400 mg at bedtime is typically prescribed.
• Active Benign Gastric Ulcer: 800 mg once daily at bedtime or 300 mg four times daily (with meals and at bedtime).
• Gastroesophageal Reflux Disease (GERD): For the relief of symptoms, 800 mg twice daily or 400 mg four times daily is common for a duration of 12 weeks.
• Pathological Hypersecretory Conditions: Dosing is highly individualized but often starts at 300 mg four times daily. Some patients may require up to 2400 mg per day depending on the severity of acid production.
• OTC Heartburn Prevention: 200 mg taken with a glass of water right before or up to 30 minutes before eating food or drinking beverages that cause heartburn. No more than 2 tablets (400 mg) should be taken in a 24-hour period.

Cimetidine use in children is less common than in adults and should only be initiated by a pediatrician.

• Infants and Children: Clinical data are limited, but dosages are generally calculated based on body weight, typically ranging from 20 to 40 mg/kg/day divided into several doses.
• Neonates: Use is extremely rare and requires specialized neonatal monitoring due to the risk of altered drug clearance.
• OTC Use: OTC cimetidine is generally not recommended for children under the age of 12 unless directed by a physician.

Renal Impairment

Because cimetidine is primarily cleared by the kidneys, patients with decreased renal function require lower doses to prevent drug accumulation and toxicity. For patients with a creatinine clearance (CrCl) of less than 30 mL/min, the recommended dose is 300 mg every 12 hours. If the patient's condition requires higher doses, the frequency may be increased with caution.

Hepatic Impairment

While the liver is not the primary route of excretion, cimetidine's metabolism can be affected by severe liver disease. Dosage should be approached conservatively, and monitoring for central nervous system side effects is essential.

Elderly Patients

Older adults are more susceptible to the side effects of cimetidine, particularly confusion and disorientation. Healthcare providers often start at the lower end of the dosing spectrum and monitor renal function closely.

• Consistency: Take cimetidine exactly as prescribed. If you are taking it once daily, the bedtime dose is often most effective at controlling 'nocturnal acid breakthrough.'
• With or Without Food: Cimetidine can be taken with or without food. Taking it with meals may slightly extend the duration of acid suppression.
• Oral Solution: Use a calibrated measuring device (not a household spoon) to ensure the correct dose is administered.
• Storage: Store tablets and liquid at room temperature (68°F to 77°F or 20°C to 25°C), away from excessive heat and moisture.

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not 'double up' or take two doses at once to make up for a missed one.

While cimetidine has a wide therapeutic index, an overdose can occur. Symptoms of overdose may include severe dizziness, fainting, extreme confusion, or labored breathing. In the event of a suspected overdose, contact your local poison control center or seek emergency medical attention immediately. Supportive care, including gastric lavage and monitoring of vital signs, is the standard clinical response.

> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop taking the medication without medical guidance, as this can lead to a return of symptoms or 'rebound' acid secretion.

Cimetidine is generally well-tolerated, but some patients may experience mild side effects as their body adjusts to the medication. Common issues include:

• Headache: This is the most frequently reported side effect. It is usually mild and transient.
• Dizziness: Some patients may feel lightheaded, particularly when rising from a sitting or lying position.
• Diarrhea: Mild gastrointestinal upset is common but rarely requires discontinuation of the drug.
• Drowsiness: A feeling of tiredness or lethargy may occur shortly after taking a dose.

• Gynecomastia: This refers to the swelling of breast tissue in males. Cimetidine has a weak anti-androgenic effect (it can block male hormones) and can increase prolactin levels. This is usually reversible upon stopping the medication.
• Muscle Pain (Myalgia): Some patients report generalized muscle aches or joint pain (arthralgia).
• Skin Rash: Mild allergic skin reactions, such as redness or itching, may occur.

• Impotence: Long-term use of high doses (such as those used for Zollinger-Ellison syndrome) has been associated with reversible erectile dysfunction.
• Blood Count Changes: Rare cases of agranulocytosis (low white blood cells), thrombocytopenia (low platelets), and aplastic anemia have been reported. These require immediate medical evaluation.
• Hepatitis: Rare instances of liver inflammation, characterized by yellowing of the skin or eyes (jaundice), have occurred.

> Warning: Stop taking Cimetidine and call your doctor immediately if you experience any of the following:

• Confusion and Hallucinations: Mental status changes are more common in the elderly or those with kidney disease. This includes disorientation, agitation, or seeing things that aren't there.
• Severe Allergic Reaction (Anaphylaxis): Symptoms include hives, swelling of the face, lips, or throat, and difficulty breathing or swallowing.
• Irregular Heartbeat (Arrhythmias): Cimetidine can rarely affect heart rhythm, particularly when given rapidly via IV. Symptoms include palpitations, a racing heart, or a very slow pulse.
• Severe Skin Reactions: Blistering, peeling, or a widespread red rash (Stevens-Johnson Syndrome) is a medical emergency.
• Signs of Infection: Fever, sore throat, or unusual weakness that could indicate a drop in white blood cell counts.

• Vitamin B12 Deficiency: Gastric acid is required for the absorption of Vitamin B12 from food. Long-term suppression of acid (typically over 2 years of therapy) can lead to a deficiency, which may cause anemia or nerve damage (neuropathy).
• Increased Risk of Infection: By reducing stomach acid, which acts as a natural barrier against bacteria, long-term use may slightly increase the risk of developing community-acquired pneumonia or Clostridioides difficile (C. diff) infections.
• Kidney Issues: Chronic use has been linked in rare cases to interstitial nephritis (inflammation of the kidney filters).

There are currently no FDA black box warnings for cimetidine. However, its extensive drug interaction profile serves as a significant clinical warning that requires careful management by healthcare providers.

Report any unusual symptoms or persistent side effects to your healthcare provider. Monitoring of blood counts and liver function may be necessary for those on long-term, high-dose therapy.

Cimetidine is a potent medication that requires careful consideration of a patient's entire medical profile. Because it affects the liver's ability to process other drugs, it is often not the first choice for patients taking multiple medications. Patients should be aware that while cimetidine treats the symptoms of acid reflux, it does not rule out the presence of more serious conditions, such as gastric cancer. If symptoms persist for more than 2 weeks of OTC use, a thorough medical evaluation is necessary.

No FDA black box warnings for Cimetidine. Despite the lack of a black box warning, the risk of central nervous system (CNS) toxicity in specific populations is a major clinical concern.

• Central Nervous System (CNS) Effects: Cimetidine can cause confusion, depressed mood, hallucinations, and seizures. These effects are most prevalent in patients over age 50, those with severely impaired renal or hepatic function, and those receiving high doses. Symptoms usually resolve within 3 to 4 days of stopping the drug.
• Masking Gastric Malignancy: Response to cimetidine therapy does not preclude the presence of a gastric malignancy (stomach cancer). Healthcare providers should consider further diagnostic testing (like an endoscopy) for patients who do not respond or who have 'alarm' symptoms like unexplained weight loss or difficulty swallowing.
• Cardiovascular Risks: Rapid intravenous administration of cimetidine has been associated with rare instances of cardiac arrhythmias and hypotension (low blood pressure). IV doses should be infused over at least 15 to 20 minutes.
• Vitamin B12 Malabsorption: Long-term acid suppression can lead to malabsorption of dietary Vitamin B12. Periodic monitoring of B12 levels may be warranted for patients on therapy for more than two years.

Patients on long-term or high-dose cimetidine therapy may require the following monitoring:

• Renal Function Tests: Creatinine and BUN (Blood Urea Nitrogen) levels to ensure the kidneys are clearing the drug effectively.
• Liver Function Tests (LFTs): To monitor for rare hepatotoxicity.
• Complete Blood Count (CBC): To check for rare blood dyscrasias like low white blood cell or platelet counts.
• Therapeutic Drug Monitoring: For drugs with narrow therapeutic indexes that interact with cimetidine (e.g., Theophylline, Warfarin).

Cimetidine may cause dizziness, drowsiness, or confusion in some patients. Do not drive, operate heavy machinery, or engage in hazardous activities until you know how this medication affects you. This is particularly important for elderly patients starting therapy.

Alcohol can irritate the stomach lining and worsen the symptoms cimetidine is intended to treat. Furthermore, some studies suggest that cimetidine may inhibit the metabolism of alcohol, leading to higher-than-expected blood alcohol levels. It is generally recommended to avoid or significantly limit alcohol consumption while taking this medication.

Abruptly stopping cimetidine after long-term use can sometimes lead to 'rebound acid hypersecretion,' where the stomach produces even more acid than before. If you have been on high doses for a long period, your doctor may recommend tapering the dose gradually.

> Important: Discuss all your medical conditions, including kidney disease, liver disease, and any history of mental health issues, with your healthcare provider before starting Cimetidine.

• Dofetilide: Cimetidine must NEVER be used with dofetilide (a heart rhythm medication). Cimetidine increases the plasma concentration of dofetilide by inhibiting its renal clearance, which significantly increases the risk of life-threatening ventricular arrhythmias (Torsades de Pointes).
• Pimozide: Concurrent use may increase pimozide levels, leading to QT prolongation and serious cardiac events.

Cimetidine is a well-known inhibitor of several cytochrome P450 enzymes (CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP3A4, and CYP2E1). This inhibition slows the metabolism of many drugs, leading to increased blood levels and potential toxicity.

• Warfarin: Cimetidine increases the anticoagulant effect of warfarin, significantly increasing the risk of bleeding. Prothrombin time (PT) and International Normalized Ratio (INR) must be monitored closely, and warfarin doses may need to be reduced.
• Theophylline: Cimetidine reduces the clearance of theophylline (used for asthma/COPD), potentially leading to theophylline toxicity (nausea, tremors, seizures). Serum theophylline levels must be monitored.
• Phenytoin: Levels of this anti-seizure medication can rise to toxic levels when taken with cimetidine.
• Clopidogrel: Cimetidine may reduce the conversion of clopidogrel to its active form, potentially reducing its effectiveness in preventing blood clots.

• Benzodiazepines: Cimetidine can increase the effects of diazepam, chlordiazepoxide, and midazolam, leading to excessive sedation.
• Beta-Blockers: It can increase the blood levels of propranolol, metoprolol, and labetalol, potentially causing excessively low blood pressure or heart rate.
• Calcium Channel Blockers: Levels of nifedipine and diltiazem may be increased.
• Tricyclic Antidepressants (TCAs): Levels of amitriptyline and nortriptyline may rise, increasing the risk of side effects.

• High-Protein Meals: May increase the secretion of gastrin, slightly counteracting the drug's effect, though not clinically significant for most.
• Caffeine: Cimetidine slows the metabolism of caffeine, which may lead to jitters, insomnia, or increased heart rate.
• Alcohol: As noted, cimetidine may increase blood alcohol concentrations by inhibiting gastric alcohol dehydrogenase.

• St. John's Wort: May induce the enzymes that cimetidine inhibits, leading to unpredictable drug levels.
• Iron Supplements: Cimetidine reduces stomach acid, which is necessary for the optimal absorption of certain iron salts. Take iron at least 2 hours apart from cimetidine.

• Creatinine Tests: Cimetidine can compete with creatinine for renal tubular secretion, which may cause a slight, false elevation in serum creatinine levels without actually indicating a decrease in kidney function.
• Skin Tests: Like other H2 blockers, cimetidine can inhibit the skin's reaction to allergen extracts. It should be discontinued several days before allergy skin testing.

For each major interaction, the mechanism usually involves the competitive inhibition of hepatic enzymes or the alteration of gastric pH. The clinical consequence is typically an increase in the toxicity of the 'victim' drug. Management strategies always involve a thorough medication review by a pharmacist or physician before starting cimetidine.

> Important: Tell your doctor about ALL medications, including over-the-counter drugs, vitamins, and herbal products, you are currently taking.

Conditions where Cimetidine must NEVER be used include:

• Hypersensitivity: Any patient with a known allergy to cimetidine or any of the inactive ingredients in the formulation. An allergic reaction can manifest as anything from a mild rash to life-threatening anaphylaxis.
• Concurrent Dofetilide Use: As previously detailed, the interaction with dofetilide is life-threatening and constitutes an absolute contraindication.
• History of H2RA-Induced Allergy: Patients who have had severe reactions to other H2-receptor antagonists (like famotidine or ranitidine) may experience cross-sensitivity and should avoid cimetidine unless cleared by an allergist.

These conditions require a careful risk-benefit analysis by a healthcare provider:

• Severe Renal Impairment: While not an absolute contraindication, the risk of CNS toxicity is so high that alternative acid-suppressants (like famotidine) are often preferred.
• Advanced Age (Geriatrics): Due to the high risk of confusion and interactions with other medications (polypharmacy), cimetidine is often avoided in the elderly per the Beers Criteria.
• Liver Cirrhosis: Patients with advanced liver disease may have impaired drug metabolism and are at higher risk for CNS side effects.
• Immunocompromised States: Because stomach acid helps kill ingested pathogens, patients with severely weakened immune systems may be at higher risk for GI infections when taking acid suppressants.

There is evidence of cross-sensitivity among the H2-receptor antagonist class. If a patient has experienced a severe skin reaction or anaphylaxis with ranitidine, famotidine, or nizatidine, the use of cimetidine is generally discouraged. However, mild side effects (like minor headaches) with one agent do not necessarily mean the patient will react the same way to cimetidine.

> Important: Your healthcare provider will evaluate your complete medical history, including any previous drug allergies and your current kidney and liver function, before prescribing Cimetidine. Always disclose if you have ever had a bad reaction to an acid-reducing medication.

Cimetidine is classified as FDA Pregnancy Category B. This means that animal reproduction studies have failed to demonstrate a risk to the fetus, but there are no adequate and well-controlled studies in pregnant women.

• First Trimester: Use should be avoided unless clearly necessary, as this is the period of organogenesis (organ formation).
• Second and Third Trimesters: Cimetidine crosses the placenta. While no specific teratogenic (birth defect) effects have been consistently linked to cimetidine in humans, it should only be used if the potential benefit justifies the potential risk to the fetus. Many obstetricians prefer other H2RAs or antacids with more robust safety data during pregnancy.

Cimetidine is excreted in human breast milk. It can concentrate in the milk at levels higher than those found in the mother's plasma. While the American Academy of Pediatrics has previously considered cimetidine compatible with breastfeeding, there is a theoretical risk that it could affect the infant's stomach acid production or interfere with drug metabolism. Nursing mothers should consult their doctor; in many cases, famotidine is preferred due to lower concentrations in breast milk.

Cimetidine is not frequently used in children. While it is approved for use in pediatric patients for certain conditions, the dosage must be strictly controlled by weight.

• Safety: The safety and effectiveness of OTC cimetidine in children under 12 have not been established.
• Growth: There are no documented long-term effects on growth, but the anti-androgenic potential of cimetidine makes it a less desirable choice for long-term use in developing children compared to other H2RAs.

Elderly patients (65 and older) are at the highest risk for adverse effects from cimetidine.

• CNS Toxicity: Confusion, agitation, and delirium are significantly more common in this age group.
• Renal Clearance: Natural age-related decline in kidney function means the drug stays in the system longer.
• Beers Criteria: Cimetidine is included in the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults due to its risk of causing or worsening delirium and its extensive drug interactions.

As the kidneys are the primary route of elimination, renal impairment is a critical consideration.

• GFR < 30 mL/min: Dose must be reduced (typically 300 mg every 12 hours).
• Dialysis: Cimetidine is removed by hemodialysis. Doses should be scheduled for after the dialysis session to ensure therapeutic levels are maintained.

In patients with compensated liver disease, cimetidine is generally safe, but in those with severe cirrhosis or hepatic encephalopathy, the drug can worsen mental status. Close monitoring for increased sedation or confusion is mandatory.

> Important: Special populations require individualized medical assessment. Never share your medication with others, especially those in these sensitive groups.

Cimetidine is a competitive, reversible inhibitor of histamine at the H2 receptors. These receptors are G-protein coupled receptors located on the gastric parietal cells. By blocking the H2 receptor, cimetidine prevents the activation of adenylate cyclase, which in turn prevents the rise of intracellular cAMP. Without cAMP, the protein kinase involved in activating the H+/K+ ATPase pump (the final step of acid secretion) remains inactive. This effectively shuts down the 'acid factory' of the stomach. Cimetidine is particularly effective at inhibiting nocturnal acid secretion, which is largely histamine-dependent, as well as meal-stimulated acid secretion.

• Onset of Action: Following an oral dose, acid suppression begins within 60 minutes.
• Duration of Effect: A single dose can suppress acid for approximately 4 to 8 hours, though this is dose-dependent.
• Tolerance: Some patients may develop 'tachyphylaxis' (a rapid decrease in response) to H2RAs after several weeks of continuous use, as the body attempts to compensate for the blocked receptors.

| Parameter | Value |

|---|---|

| Bioavailability | 60% - 70% |

| Protein Binding | 13% - 25% |

| Half-life | 2 hours (increases in renal failure) |

| Tmax | 45 - 90 minutes |

| Metabolism | Hepatic (CYP450 inhibitor) |

| Excretion | Renal (48% unchanged) |

• Molecular Formula: C10H16N6S
• Molecular Weight: 252.34 g/mol
• Solubility: Soluble in water (1.14 g/100 mL at 37°C), alcohol, and dilute mineral acids.
• Structure: It contains an imidazole ring, which is structurally related to histamine, allowing it to fit into the H2 receptor site without triggering a response.

Cimetidine belongs to the Histamine-2 Receptor Antagonist [EPC] class. It was the first of this class, followed later by ranitidine (now largely withdrawn), famotidine, and nizatidine. While all H2RAs share the same primary mechanism of acid suppression, cimetidine is unique in its significant inhibition of the cytochrome P450 enzyme system.